SSR2 and meningioma: Marincek et al. [36] investigated the long-term outcome of PRRT in 34 patients with histologically confirmed meningiomas, progressive after surgery and/or RT within 12 months before enrollment, characterized by SSR2 expression detected through conventional 111In-pentetreotide scintigraphy.